Trump’s HHS Deputy Pick Previously Urged Drug Approval Reform, Opposed FDA Reg Of LDTs, Algorithms

President-elect Donald Trump’s pick for HHS deputy -- Jim O’Neill, an executive with ties to Silicon Valley and a former HHS official during George W. Bush’s administration -- once made waves by suggesting FDA should consider only the safety of drugs in approval decisions, leaving efficacy as a post-market consideration. He also previously opposed FDA oversight of laboratory-developed tests that used algorithms. O’Neill would be Robert F. Kennedy Jr.’s second-in-command at HHS if both are confirmed by the Senate. Trump...